- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06568120
Effect of Using a Dragon Design Nebulizer Mask on Treatment Duration, Compliance and Fear in Children
Effect of Using a Dragon Design Nebulizer Mask on Treatment Duration, Compliance and Fear in Children Presenting to the Emergency Department: A Randomized Controlled Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The meaning of a disease or medical procedure may vary depending on the child's developmental milestones. Children aged 3-6 years, who are in the preoperational stage of cognitive development as defined by Piaget, often perceive hospital environments with curiosity and fear. This age group is characterized by a vivid imagination and limited understanding of the cause-and-effect relationship, which can lead to misconceptions about medical procedures and devices. For example, they may believe that they are being punished or that procedures or medical devices are more painful than they are. They may react with heightened anxiety, clinginess, or aggression. Even using face masks for aerosol therapy may cause distress in young children, as the masks can be perceived as scary or uncomfortable. Young children prefer a hospital environment that is bright, cheerful, warm, colorful, and comfortable. These environmental factors help reduce anxiety and create a more welcoming and less intimidating atmosphere for young patients.
Emergency rooms are often not designed to accommodate agitated young patients, featuring physical layouts that are not conducive to their care, noisy and chaotic environments, and limited access to therapeutic spaces. The care team may also lack the resources to manage agitated children effectively. On the other hand, recent studies have highlighted the importance of creating child-friendly medical environments to reduce anxiety and improve cooperation during treatment. This study aims to evaluate the impact of using dragon/turtle-themed nebulizer masks on treatment application time, treatment adherence, and fear levels in children who present to emergency rooms.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Eyşan Hanzade Savaş, PhD
- Phone Number: 5068418841
- Email: eumac14@ku.edu.tr
Study Locations
-
-
-
Istanbul, Turkey
- Koç University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Aged between 3-6 years,
- Presenting to the emergency department with a respiratory problem (such as an upper respiratory tract infection) requiring nebulizer treatment,
- In general good health and suitable for nebulizer treatment (i.e., not having conditions like severe allergies or chronic respiratory failure),
- Possessing age-appropriate language and communication skills,
- Not previously familiar with the dragon-themed masks,
- Having parental consent.
Exclusion Criteria:
- Children with major medical or psychiatric comorbidities as reported by the physician, nurse, or parent,
- Children with a chronic health condition requiring regular nebulizer use (such as asthma),
- Children with a fever of 38°C (100.4°F) or higher,
- Children who have started treatment with sedative or anticonvulsant medications,
- Children and parents with visual, auditory, verbal, or cognitive impairments that would interfere with the use of the intervention equipment.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Standard care
Children aged 3-6 who require nebulizer treatment in the emergency department, along with their families, will first be informed by one of the researchers.
Then, children who are randomly assigned to the control group will be treated according to the institution's standard care procedures.
The child and their family will be informed immediately before the treatment procedure.
During the treatment, the child will be treated using a standard nebulizer mask appropriate for their age, in accordance with the institution's routine care procedures, and the parent will remain with the child throughout the treatment.
The child's level of fear will be assessed by both the child and the nurse before and during the treatment.
Additionally, the nurse will record the total duration of inhaler treatment and the child's adherence to the treatment.
|
|
|
Experimental: Dragon Mask Group
Children who present to the emergency department and require nebulizer treatment will be randomly assigned to either the experimental or control groups.
First, one of the researchers will meet with the child and their parent to provide information about the study.
If the child and family agree to participate and are assigned to the experimental group, the child will be asked which mask design they prefer to use during the inhaler treatment: a dragon or a turtle.
Additionally, before the treatment, the fear level of each child will be assessed by both the child and the nurse.
During the treatment process, the children will receive nebulizer treatment appropriate for their age, and the duration and adherence to the treatment will be recorded by the nurse.
Similarly, fear levels will be measured immediately before and during the treatment.
|
This study is an experimental investigation aiming to evaluate the effect of a dragon-themed nebulizer mask (Figure 1), identified during a literature review by the researchers, on the duration of inhaler treatment application, treatment adherence, and children's fear levels.
The dragon-designed nebulizer mask, with its colorful and toy-like appearance, is intended to calm children using pediatric aerosol masks.
The mask is made of very soft, latex-free plastic, ensuring comfortable use for pediatric patients.
It is compatible with all nebulizers and suitable for use in hospital settings.
Unlike standard nebulizer masks, its appearance is designed with a dragon character specifically for pediatric patients.
The mask is manufactured in China.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Fear - Child Fear Scale
Time Frame: Immediately before (baseline) treatment (approximately 5 minutes before), each child's fear level will be assessed by the child and the nurse. Similarly, fear levels will be measured again during the intervention.
|
Thurillet et al. (2022) is used to learn about children's fears based on the autobiographical stories of children aged 4-12.
The Turkish adaptation was made by Tavşan et al. in 2023.
The scale consists of six facial expressions.
The scale is graded with a score between 0 and 10 (graded gradually by two) along with fear and pain rating rates.
It is seen that the first facial expression does not indicate fear, fear increases from right to left, and fear is most common in people's facial expressions.
|
Immediately before (baseline) treatment (approximately 5 minutes before), each child's fear level will be assessed by the child and the nurse. Similarly, fear levels will be measured again during the intervention.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Duration of Treatment and Compliance
Time Frame: During the intervention, children will be given nebulizer treatment appropriate to their age, and the duration of treatment and compliance will be recorded by the nurse. This takes an average of 15-20 minutes.
|
The start and end times of the inhaler treatment of the children in the experimental and control groups, as well as whether the children have complied with the treatment, will be evaluated with a form.
The children in the experimental and control groups will be observed by nurses throughout the treatment period.
The treatment durations of the children and their behaviors towards the treatment will be recorded as follows.
|
During the intervention, children will be given nebulizer treatment appropriate to their age, and the duration of treatment and compliance will be recorded by the nurse. This takes an average of 15-20 minutes.
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Eyşan Hanzade Savaş, PhD, Koç University
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- kocuniversty
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Fear
-
NYU Langone HealthCompleted
-
Cairo UniversityUnknownInjection Fear, Fear, Avoidance, Dental
-
Cukurova UniversityCompletedPregnancy | Fear | Education | Fear of Childbirth | BirthTurkey
-
KK Women's and Children's HospitalRecruitingAnxiety | Pregnancy Related | Fear | Fear of Childbirth | Anxiety and FearSingapore
-
New York UniversityCompleted
-
Riyadh Colleges of Dentistry and PharmacyCompleted
-
Ondokuz Mayıs UniversityCompletedFear | Wound Care | Fear Anxiety | Distraction | Distraction Methods | Children Pain ManagementTurkey (Türkiye)
-
Fundacion Miguel ServetUniversidad Pública de NavarraCompleted
-
University of California, Los AngelesNational Institute of Mental Health (NIMH)Enrolling by invitation
-
University of GuelphNatural Sciences and Engineering Research Council, CanadaCompleted